10
Participants
Start Date
January 31, 2012
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Abatacept
"Subjects will receive approximately 10 mg/kg rounded to the nearest 25 mg for the first 6 months of the trial. At 6 months subjects will then be randomized to receive either 5 mg/kg or 10 mg/kg.~Abatacept will be administered as a 30-minute intravenous infusion. Following the initial administration, abatacept will be given at 2 and 4 weeks after the first infusion and every 4 weeks thereafter for up to 2 years."
Oregon Health & Science University, Portland
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Oregon Health and Science University
OTHER